<DOC>
	<DOC>NCT00666302</DOC>
	<brief_summary>A study to compare efficacy of Protopic Ointment to that of Elidel Cream in treating patients with Atopic Dermatitis</brief_summary>
	<brief_title>A Comparison Study Between Protopic (Tacrolimus) Ointment and Elidel (Pimecrolimus) Cream in Treating Subjects With Atopic Dermatitis</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis, Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Pimecrolimus</mesh_term>
	<criteria>Diagnosis of Atopic Dermatitis rated at least mild using the Investigator's Global Atopic Dermatitis Assessment involving a minimum of 5% of the body surface area Negative pregnancy test and agrees to practice effective birth control during the study Skin disorder other than Atopic Dermatitis in the areas to be treated Extensive scarring or pigmented lesions in the areas to be treated that would interfere with rating of efficacy parameters Clinically infected Atopic Dermatitis at baseline Likely to require systemic corticosteroids; or likely to require intranasal or inhaled corticosteroids for an offlabel indication or at higher doses than the maximum labeled dosing for the drug Known hypersensitivity to macrolides or any excipient of either study medication Chronic condition which is either not stable or not well controlled Pregnant or breast feeding an infant</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Atopic Dermatitis</keyword>
	<keyword>Protopic</keyword>
	<keyword>Elidel</keyword>
</DOC>